Click a link below to view the mailing archive as if it had been sent to you.
| 2023-10-31 12:15 | | The 2023 Biotech Graveyard and more... |
| 2023-10-31 00:15 | | A brain-focused biotech raises $225M to develop drugs for schizophrenia, Parkinson’s and more... |
| 2023-10-30 12:15 | | Merck KGaA pays $169M for selective PARP1 drug, stepping up challenge to AstraZeneca and Gilead and more... |
| 2023-10-30 00:15 | | ‘We knew it was there’: AbbVie CEO says company favored internal work over potential Daiichi deal and more... |
| 2023-10-27 12:15 | | Lilly’s ulcerative colitis therapy mirikizumab finally snags FDA approval and more... |
| 2023-10-27 00:15 | | Bristol-Myers (BMY) Q3 Earnings & Sales Beat, Opdivo Sales Grow and more... |
| 2023-10-26 12:15 | | Pfizer, BioNTech prep flu-COVID mRNA combo shot for phase 3, reprising Moderna race after seeing early data and more... |
| 2023-10-26 00:15 | | Mediar gets a spark from Pfizer’s Ignite scheme as lead fibrosis programs progress and more... |
| 2023-10-25 12:15 | | 'By hook or by crook': BIO CEO urges biotechs to be flexible on funding to survive tough times and more... |
| 2023-10-25 00:15 | | Amgen plans to lay off 350 former Horizon employees after $28B buyout and more... |
| 2023-10-24 12:15 | | Pfizer’s new shot approval adds to a growing vaccine prowess and more... |
| 2023-10-24 00:15 | | ESMO: AstraZeneca-Daiichi get clarity on patient deaths for Enhertu follow up Dato-DXd, survival data still unclear and more... |
| 2023-10-23 12:15 | | Roche pays $7.1B to Roivant for rights to Telavant’s IBD candidate and more... |
| 2023-10-23 00:15 | | Pfizer beats out GSK with FDA nod for first 5-in-1 meningitis shot and more... |
| 2023-10-20 12:15 | | Jazz looks at strategic options, including possible sale or unit divestiture and more... |
| 2023-10-20 00:15 | | Pfizer and Moderna Don't See Eye to Eye on This 1 Particular Point and more... |
| 2023-10-19 12:15 | | Roche drops oral eye disease drug after completing phase 2, pulls back from solid tumor bispecific and more... |
| 2023-10-19 00:15 | | Pfizer to pay $2M settlement for alleged gender wage discrimination and more... |
| 2023-10-18 12:15 | | ESMO: Seagen, Astellas and Merck knock it out of the park with Padcev-Keytruda combo in bladder cancer and more... |
| 2023-10-18 00:15 | | FDA approves Ardelyx's kidney disease-related drug and more... |
| 2023-10-17 12:15 | | Thermo Fisher Scientific to buy Olink in $3.1 billion deal and more... |
| 2023-10-17 00:15 | | COVID shot sales: Pfizer lowers outlook, Moderna maintains guidance and more... |
| 2023-10-16 12:15 | | AbbVie trumpets Skyrizi's resounding win against J&J's Stelara in Crohn's disease and more... |
| 2023-10-16 00:15 | | Rite Aid files for bankruptcy, gets $3.45 bln commitment and more... |
| 2023-10-15 00:15 | | Pfizer to cut costs, lay off staff on waning demand for COVID products |
| 2023-10-14 00:15 | | High-flying Novo Nordisk once again dials up its 2023 sales and profit expectations and more... |
| 2023-10-13 12:15 | | Amylyx’s ALS drug knocked back again in Europe and more... |
| 2023-10-13 00:15 | | Alnylam CEO, ‘disappointed’ with FDA’s Onpattro rejection, pivots to the future and more... |
| 2023-10-12 12:15 | | Massachusetts Biopharma Job Growth Surpasses that of Other States: Report and more... |
| 2023-10-12 00:15 | | Biogen lays off staffers at newly acquired Reata, with 113 set to lose positions and more... |
| 2023-10-11 12:15 | | Biotech Bankruptcies Skyrocket and more... |
| 2023-10-11 00:15 | | Akita Biosciences Launches to Pioneer Novel Intranasal Therapies and more... |
| 2023-10-10 12:15 | | Bayer christens $250M cell therapy 'launch facility' in Berkeley and more... |
| 2023-10-10 00:15 | | FDA Decision On Interchangeable Exclusivity Allows Pfizer To Rival Boehringer On Adalimumab and more... |
| 2023-10-09 12:15 | | After pandemic sugar rush, a market 'hangover' opens biotech to funding approaches steeped in stigma and more... |
| 2023-10-09 00:15 | | Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics and more... |
| 2023-10-06 12:15 | | Largest dataset of thousands of proteins a landmark step for research into human health and more... |
| 2023-10-06 00:15 | | Months after FDA slam, AbbVie buys Parkinson’s disease drugmaker Mitokinin and more... |
| 2023-10-05 12:15 | | FDA Puts Innate’s Lymphoma Trials on Partial Hold After Patient Death and more... |
| 2023-10-05 00:15 | | How a big pharma company stalled a potentially lifesaving vaccine in pursuit of bigger profits and more... |
| 2023-10-04 12:15 | | Boehringer Ingelheim embraces dual-pricing tactic with launch of unbranded Humira biosimilar and more... |
| 2023-10-04 00:15 | | US Patent Office won't review two Novo Nordisk patents for Wegovy, Ozempic and more... |
| 2023-10-03 12:15 | | Lilly Deepens Oncology Pipeline with $1.4B Point Biopharma Purchase and more... |
| 2023-10-03 00:15 | | US judge refuses to block Medicare from negotiating drug prices and more... |
| 2023-10-02 12:15 | | Novo Nordisk challenges CMS drug price negotiations, then signs on to the program and more... |
| 2023-10-02 00:15 | | FDA Launches Pilot Program to Help Further Accelerate Development of Rare Disease Therapies and more... |
